Drrx stock forecast.

CUPERTINO, Calif., July 20, 2023 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) ("DURECT"), a biopharmaceutical company focused on developing its epigenetic regulator program for the treatment ...eCommerce double-digit growth in Q3 and share buyback of $18.6M. Raised 2023 Adjusted EBITDA range to $75M - $82M and Non-GAAP Net Income range to $7M - $12M.Zacks Equity Research. A downtrend has been apparent in Durect (DRRX) lately with too much selling pressure. The stock has declined 17.1% over the past four weeks. However, given the fact that it ...Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week.DURECT Corp ( DRRX) is up 3.29% today. DRRX has an Overall Score of 75. Find out what this means to you and get the rest of the rankings on DRRX! DRRX stock closed at $7.00 and is up $0.23 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard …

Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.Doing some research is necessary before pulling the trigger on any penny stock. Following the recommendations from Wall Street pros can help in the due diligence process. Bearing this in mind, we used the TipRanks database to take a look at two penny stocks getting rave reviews from Oppenheimer analyst Francois Brisebois, with the firm’s …Based on short-term price targets offered by two analysts, the average price target for Durect comes to $6.75. The forecasts range from a low of $5.00 to a high of $8.50. The average price target ...

Durect Corp. DRRX (U.S.: Nasdaq) Overview News Durect Corp. No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) N/A EPS (TTM) $-1.53 Market Cap …

Celebrations may be in order for DURECT Corporation ( NASDAQ:DRRX ) shareholders, with the analysts delivering a...The U.S. National Weather Service (NWS) is a part of the National Oceanic and Atmospheric Administration (NOAA). Many people rely on the National Weather Service’s forecasts in order to better anticipate what the weather will be like so the...Heading out for an outdoor adventure? Whether you’re planning a picnic, a hiking trip, or a beach day, one essential tool you need in your arsenal is a detailed weather 10 day forecast.Nasdaq provides market information on after hours trading daily from 4:15 p.m. ET to 3:30 p.m. ET on the following day. $233.0401 -1.2599 -0.54%. $190.76 +1.07. DURECT Corporation Common Stock ... DRRX Stock USD 6.40 0.02 0.31% Durect stock price prediction is an act of determining the future value of Durect shares using few different conventional methods such as EPS estimation , analyst consensus, or fundamental intrinsic valuation .

Alzamend Neuro® is a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s disease, Bipolar disorder, Major Depressive Disorder (“MDD”) and Post-Traumatic Stress Disorder (“PTSD”). Our mission is to rapidly develop and market safe and effective treatments to bring aid to the 43 ...

DRRX stock recorded 20/30 (67%) green days with 62.91% price volatility over the last 30 days. Based on our DURECT stock forecast, it's now a bad time to buy DRRX stock because it's trading 19.19% above our forecast. Disclaimer: This is not investment advice. The information provided is for general information purposes only.

Find the latest DURECT Corporation (DRRX) stock quote, history, news and other vital information to help you with your stock trading and investing.A. The latest price target for Durect ( NASDAQ: DRRX) was reported by JonesTrading on Thursday, November 9, 2023. The analyst firm set a price target for 0.00 expecting DRRX to fall to within 12 ...Stock Price Forecast. According to 2 stock analysts, the average 12-month stock price forecast for DURECT stock is $36.5, which predicts an increase …Stock Price Forecast. The 4 analysts offering 12-month price forecasts for DURECT Corp have a median target of 17.75, with a high estimate of 37.00 and a low estimate of 5.00. The median...Nasdaq provides market information on after hours trading daily from 4:15 p.m. ET to 3:30 p.m. ET on the following day. $233.0401 -1.2599 -0.54%. $190.76 +1.07. DURECT Corporation Common Stock ...Stock Price Forecast. The 4 analysts offering 12-month price forecasts for DURECT Corp have a median target of 17.75, with a high estimate of 37.00 and a low estimate of 5.00. The median... Read today's DRRX news from trusted media outlets at MarketBeat. Skip to main content. S&P 500 4,514.02. DOW 34,947.28. QQQ 386.04. S&P 500's Whirlwind: Big gains, warning whispers & tactical moves. Trading Experts Call It “The Perfect Tesla Trade” (Ad) ... Durect Shares Slide Premarket on Planned Stock Sale >DRRX marketwatch.com ...

Last reporting date. November 22, 2023. EPS forecast (this quarter) -$0.86. Annual revenue (last year) $0.00. Annual profit (last year) -$14.6M. Net profit margin.The latest Durect stock prices, stock quotes, news, and DRRX history to help you invest and trade smarter. ... Vanguard Total Stock Market ETF: 2.48: Armistice Capital LLC: 2.21: Vanguard Russell ...Story continues. DURECT Corporation (Nasdaq: DRRX), a biopharmaceutical company focused on developing epigenetic regulator programs for the treatment of acute organ injury and chronic liver ...Durect (DRRX) In a report released today, Kristen Kluska from Cantor Fitzgerald reiterated a Buy rating on Durect, with a price target of $44.00 . The company’s shares closed last Wednesday at ...DURECT Corporation Common Stock (DRRX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Stock Price Forecast. The 4 analysts offering 12-month price forecasts for DURECT Corp have a median target of 17.75, with a high estimate of 37.00 and a low estimate of 5.00. The median...

GEVO Stock 12 Months Forecast. $6.47. (528.16% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Gevo in the last 3 months. The average price target is $6.47 with a high forecast of $14.00 and a low forecast of $2.00. The average price target represents a 528.16% change from the last price of $1.03.

NSD:DRRX Detailed Stock Analysis, Stock Price Forecasts, Analyst Ratings, Financial Analysis, Stock News & Historic QuotesWall Street Analysts Think Durect (DRRX) Could Surge 594.98%: Read This Before Placing a Bet Zacks - Thu May 11, 8:55AM CDT . The mean of analysts' price targets for Durect (DRRX) points to a 595% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in...Real time Durect (DRRX) stock price quote, stock graph, news & analysis.Interested in getting the full scoop on DRRX, including earnings and dividends, stock forecast, buy or sell analysis and key stats? If so, you came to the right place. In this DRRX stock guide , we'll address key questions about DRRX, above and beyond what you can find on Yahoo Finance, Zacks, MarketWatch or Morningstar.On March 14, 2023, JonesTrading initiated coverage of DURECT with a Buy recommendation. Analyst Price Forecast Suggests 660.43% Upside. As of March 14, 2023, the average one-year price target for ...NSD:DRRX Detailed Stock Analysis, Stock Price Forecasts, Analyst Ratings, Financial Analysis, Stock News & Historic QuotesGet the latest Microvast Holdings Inc (MVST) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Bollinger Bands charts for DRRX (Durect Corporation). Bollinger Bands consist of a set of three curves drawn in relation to securities prices.Elys delivers a true state-of-the-art betting platform, capable of processing any type of digital game content. From integrated sports and virtual betting solutions to any third-party content including online casino & slot games, poker, bingo, lottery plus all types of interactive games, we have decades of experience offering it all.. The difference is the Elys’ …On average, Wall Street analysts predict that Durect 's share price could reach $34.00 by Aug 10, 2024. The average Durect stock price prediction forecasts a potential upside …

Nov 8, 2023 · DRRX Stock Performance on November 8, 2023: On November 8, 2023, DRRX stock had a volatile day of trading. The stock opened at $0.83 and traded in a range of $0.58 to $0.83 throughout the day. The trading volume was 693,861 shares. DRRX is a pharmaceutical company based in Cupertino, California, with a market capitalization of $75.3 million.

Stock Price Forecast. The 4 analysts offering 12-month price forecasts for DURECT Corp have a median target of 17.75, with a high estimate of 37.00 and a low estimate of 5.00. The median...

DURECT Stock Earnings. The value each DRRX share was expected to gain vs. the value that each DRRX share actually gained. DURECT ( DRRX) reported Q3 2023 earnings per share (EPS) of -$0.11, beating estimates of -$0.41 by 72.98%. In the same quarter last year, DURECT 's earnings per share (EPS) was -$0.11. DURECT is expected to release next ... /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) ... The shares of common stock and accompanying warrants are being sold at a combined purchase price of $5.015 per share and accompanying warrant.May 17, 2023 · Durect (DRRX) In a report released today, Kristen Kluska from Cantor Fitzgerald reiterated a Buy rating on Durect, with a price target of $44.00 . The company’s shares closed last Wednesday at ... Find the latest DURECT Corporation (DRRX) stock analysis from Seeking Alpha’s top analysts: exclusive research and insights from bulls and bears.DRRX's stock price has decreased by -84.09% in the past year and price targets may not have had time to catch up. Stock Price Forecast According to 2 stock analysts, the average 12-month stock price forecast for DURECT stock is $36.5, which predicts an increase of 5,499.88%.The average one-year price target for DRRX / Durect Corp is $6.885. The forecasts range from a low of $5.05 to a high of $8.925. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or ...A share price of Durect Corp [DRRX] is currently trading at $2.92, up 12.31%. An important factor to consider is whether the stock is rising or falling in short-term value. The DRRX shares have gain 13.62% over the last week, with a monthly amount glided 3.55%, and seem to be holding up well over aNasdaq Dividend History provides straightforward stock’s historical dividends data. Dividend payout record can be used to gauge the company's long-term performance when analyzing individual stocks.

Wall Street Analysts Think Durect (DRRX) Could Surge 594.98%: Read This Before Placing a Bet Zacks - Thu May 11, 8:55AM CDT . The mean of analysts' price targets for Durect (DRRX) points to a 595% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in... We’ve all flipped between different weather apps, wondering why each is giving a slightly different report. Before we look at AccuWeather, it’s important to understand the basics of weather forecasting. In the past, weather predictions were...Based on short-term price targets offered by two analysts, the average price target for Durect comes to $6.75. The forecasts range from a low of $5.00 to a high of $8.50. The average price target ... Stock Price Forecast. The 8 analysts offering 12-month price forecasts for EyePoint Pharmaceuticals Inc have a median target of 28.00, with a high estimate of 55.00 and a low estimate of 20.00 ...Instagram:https://instagram. cash cow etfproblems with wind turbinesregulated forex brokersdanher stock (See DRRX stock forecast) Ovid Therapeutics . Next up is Ovid Therapeutics, a biopharmaceutical company working to develop new medications for the treatment of rare neurological disorders, ...NSD:DRRX Detailed Stock Analysis, Stock Price Forecasts, Analyst Ratings, Financial Analysis, Stock News & Historic Quotes mock stock trading apptop annuity Overall, the bulls take the lead on this one. Out of 5 total reviews published in the last three months, all 5 analysts rated the stock a Buy. Therefore, the message is clear: AVDL is a Strong Buy ...Weather forecasting plays a crucial role in our daily lives, helping us plan our activities and make informed decisions. But have you ever wondered how meteorologists are able to accurately predict the weather? One of the key components in ... graphite company stocks On June 7, 2023, DURECT Corporation announced the successful completion of enrollment for Phase 2b AHFIRM clinical trial. The trialOur stock price may be volatile, and your investment in our common stock could decline in value. The market prices for securities of healthcare companies in ...